This section details the equations that define and support the Additional Dosage Routes features in GastroPlus®. See:
Intramuscular and Subcutaneous Compartments Equations
Equation 7-1: Transport for a perfusion-limited SubQ compartment between the SubQ compartment and systemic circulation
where:
|
Variable |
Definition |
|
|
The mass of unbound drug that is in the SubQ compartment. |
|
|
The local tissue blood flow rate. |
|
|
The total concentration of drug in the arterial blood. |
|
|
The total concentration of drug in the SubQ compartment. |
|
|
The drug blood to plasma concentration ratio. |
|
|
The partition coefficient for the drug between the SubQ and plasma. |
|
|
The hematocrit. |
|
|
The lymphatic flow rate as a percentage of the plasma flow rate. |
|
|
The partition coefficient for the drug between the plasma and SubQ extracellular fluid. |
|
|
The local clearance rate at the injection site. |
Equation 7-2: Transport for a permeability-limited SubQ compartment between the extracellular compartment and systemic circulation
Equation 7-3: Transport for a permeability-limited SubQ compartment between the extracellular compartment and the intracellular compartment
where:
|
Variable |
Definition |
|
|
The mass of unbound drug in the extracellular space in the SubQ compartment. |
|
|
The total amount of drug in the intracellular space in the SubQ compartment. |
|
|
The local tissue blood flow rate. |
|
|
The total concentration of drug in the arterial blood. |
|
|
The total concentration of drug in the extracellular space in the SubQ compartment. |
|
|
The concentration of unbound drug in the extracellular space in the SubQ compartment. |
|
|
The concentration of unbound drug in the intracellular space in the SubQ compartment. |
|
|
The drug blood to plasma concentration ratio. |
|
|
The partition coefficient for the drug between the SubQ and plasma. |
|
|
The hematocrit. |
|
|
The lymphatic flow rate as a percentage of the plasma flow rate. |
|
|
The partition coefficient for the drug between the plasma and SubQ extracellular fluid. |
|
|
The permeability surface area parameter in the SubQ. |
|
|
The local clearance rate in the extracellular space in the SubQ compartment. |
|
|
The local clearance in the intracellular space in the SubQ compartment. |
Equation 7-4: Transport for a perfusion-limited IM compartment between the intramuscular compartment and systemic circulation
where:
|
Variable |
Definition |
|
|
The mass of unbound drug that is in the IM compartment. |
|
|
The local tissue blood flow rate. |
|
|
The total concentration of drug in the arterial blood. |
|
|
The total concentration of drug in the IM compartment. |
|
|
The drug blood to plasma concentration ratio. |
|
|
The partition coefficient for the drug between the muscle and plasma. |
|
|
The hematocrit. |
|
|
The lymphatic flow rate as a percentage of the plasma flow rate. |
|
|
The partition coefficient for the drug between the plasma and muscle extracellular fluid. |
|
|
The local clearance rate at the injection site. |
Equation 7-5: Transport for a permeability-limited IM compartment between the extracellular compartment and systemic circulation
Equation 7-6: Transport for a permeability-limited IM compartment between the extracellular compartment and the intracellular compartment
where:
|
Variable |
Definition |
|
|
The mass of unbound drug in the extracellular space in the IM compartment. |
|
|
The total amount of drug in the intracellular space in the IM compartment. |
|
|
The local tissue blood flow rate. |
|
|
The total concentration of drug in the arterial blood. |
|
|
The total concentration of drug in the extracellular space in the IM compartment. |
|
|
The concentration of unbound drug in the extracellular space in the IM compartment. |
|
|
The concentration of unbound drug in the intracellular space in the IM compartment. |
|
|
The drug blood to plasma concentration ratio. |
|
|
The partition coefficient for the drug between the muscle and plasma. |
|
|
The hematocrit. |
|
|
The lymphatic flow rate as a percentage of the plasma flow rate. |
|
|
The partition coefficient for the drug between the plasma and muscle extracellular fluid. |
|
|
The permeability surface area parameter in the muscle. |
|
|
The local clearance rate in the extracellular space in the IM compartment. |
|
|
The local clearance in the intracellular space in the IM compartment. |
Equation 7-7: Effective depot volume calculation
Equation 7-8: Change in effective depot volume with time as the result of tissue inflammation
|
Variable |
Definition |
|
|
The effective depot volume at time t. |
|
|
The effective depot volume at time 0, which represents the volume of the SubQ tissue compartment. |
|
|
The magnitude of inflammation at time t as defined for the Inflammation versus Time profile. |
|
|
A scaling factor for the Inflammation at time t. This parameter allows for a quick scaling of the entire Inflammation versus Time profile, or to assign a different magnitude of inflammation in the muscle and adipose compartments with simultaneous subcutaneous and intramuscular injection, which occurs when the injection point is between the two tissues. |
Equation 7-9: Inflammation equation parameters
where:
|
Variable |
Definition |
|
|
The lag time allowed for delaying the inflammation. |
|
|
User-defined constants that account for the body’s responses to the various drug formulations. |